Endometriosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Endometriosis is a painful medical condition in which the endometrium, the tissue that lines the inner part of the uterus, grows outside the uterus. Endometriosis tissue can be found in the fallopian tubes, ovaries, and pelvic tissue. Endometrial tissue that has been displaced acts normally in endometriosis, thickening, breaking down, and eventually bleeding as it does during every menstrual cycle. Because there is no other way for the displaced tissue to exit the body, it becomes trapped outside the uterus. Endometriosis causes cysts called endometriomas when the ovaries are involved. As a result, the surrounding tissues form an adhesion or scar tissue near the ovaries (abnormal bands of fibrous tissue that cause pelvic organs and tissues to stick together).

The presence of a late-stage robust product pipeline, the global increase in cases, and several initiatives are undertaken by the government and key players at the national and international levels to raise disease awareness are attributed to Endometriosis Treatment Market.

Oral contraceptives are highly preferable as a first-line treatment for patients without contraindications due to their efficacy in preventing the recurrence of pelvic pain and endometriosis lesions. Endometriosis Treatment Market, however, is associated with potential side effects such as mood changes, nausea, and elevated blood pressure levels. Progestins, on the other hand, must be taken on a regular basis, unlike oral contraceptives.

Globally, there is a greater emphasis on women's diseases, and new drugs and treatments are being developed to alleviate their suffering. Endometriosis is a common disease that affects approximately 170 million women worldwide. Because endometriosis affects so many women, significant advances in endometriosis treatment are being made by incorporating cutting-edge technologies. Because Endometriosis Treatment Market is in high demand, significant efforts are being made to improve diagnosis methods. Most importantly, women around the world are becoming more aware of and vocal about their situation, making growth in this market highly profitable and significant.

Key Players

Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc. are key players in the global endometriosis treatment market.

x